Position in AXGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,745,916
+$1,059,140 QoQ
Shares Held
81,098
0.0% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#87
of 252 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026B. Metzler seel. Sohn & Co. AG holds $197,666,357 across 14 Medical Devices names. AXGN ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,311,875 | $119,039,537 | |
| 2 | SYK |
Stryker Corp
|
120,896 | $38,062,896 | |
| 3 | BSX |
Boston Scientific Corp
|
333,583 | $14,237,322 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
83,210 | $5,326,271 | |
| 5 | EW |
Edwards Lifesciences Corp
|
41,753 | $3,776,976 | |
| 6 | AXGN |
Axogen, Inc.
This page
|
81,098 | $3,745,916 | |
| 7 | DXCM |
Dexcom Inc
|
47,413 | $3,193,265 | |
| 8 | GMED |
Globus Medical Inc
|
30,655 | $2,422,051 |
All Filings in AXGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,745,916 | 81,098 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,686,776 | 81,098 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,946,289 | 59,465 | Shares | Defined | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||